What Researchers Did
Researchers looked back at the records of 24 patients with stage III-IV gastric cancer who were treated with chemotherapy plus a ketogenic diet, local hyperthermia, and hyperbaric oxygen therapy (HBOT) between April 2014 and October 2017.
What They Found
This retrospective study of 24 patients with advanced gastric cancer reported a complete response in 22 patients (88.0%) after combined chemotherapy, ketogenic diet, hyperthermia, and HBOT, with a mean overall survival of 39.5 months. Mean follow-up was 23.9 months, with a standard deviation of 12.7 months. Mean progression free survival was 36.5 months (95% CI: 25.7-47.2), and mean overall survival had a 95% CI of 28.1-51.0 months. The abstract states that no problems were encountered due to fasting, hypoglycemia, the ketogenic diet, hyperthermia, or HBOT.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small, retrospective study of 24 patients with no comparison group, so it cannot show that the combination caused the reported outcomes or that HBOT played any role in them.